Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
Acute therapies continue to report strong growth compared to chronic ones.
This capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into an e-learning one
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
Subscribe To Our Newsletter & Stay Updated
